Clinical trial
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating…
NCT00014222 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00014222 |
|---|---|
| Title | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer |
| Official title | A Phase III Adjuvant Trial Of Sequenced EC + Filgrastim + Epoetin Alfa Followed By Paclitaxel Versus Sequenced AC Followed By Paclitaxel Versus CEF As Therapy For Premenopausal Women And Early Postmenopausal Women Who Have Had Potentially Curative Surgery For Node Positive Or High Risk Node Negative… |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | North Central Cancer Treatment Group SWOG Cancer Research Network Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | epoetin alfa, filgrastim, cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, fluorouracil, paclitaxel |
| Enrollment | 2,104 |
| Start date | Dec 4, 2000 |
| Primary completion | Feb 10, 2014 |
| Completion | Mar 17, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 5, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: